Personalized mRNA vaccine boosts melanoma immunotherapy

2 min read Original article ↗

Adjuvant checkpoint inhibitor therapy is the standard of care for resectable melanoma. Although many patients derive lasting benefit from the treatment, a substantial number experience disease recurrence.

Nature Careers

Jobs